Skip to main content

BEDEL FINANCIAL CONSULTING INC

Location
INDIANAPOLIS, IN
Portfolio Value
Micro $9,580,570
Diversification
Highly concentrated
Filing Date
Sep 30, 2023
Global Rank
#2,661 / 6,895
Top Industry
Drug Manufacturers - General 64.3%
3Y Alpha vs SPY
+1.5%
Period ended 2 years ago
Filed Nov 1, 2023 · 2y

Clone Performance

Nov 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+76.0%
SPY
+70.5%
Annualised alpha
+1.5%
Max drawdown
−19.7%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

131 positions · as of Sep 30, 2023
Top Position
60.1%
of portfolio value
Top 5
73.5%
of portfolio value
Top 10
78.5%
of portfolio value
HHI
3,678
Highly concentrated

Sector Breakdown

As of Sep 30, 2023
Sector % Portfolio Value
Healthcare 64.3% $187,016,361
Technology 12.3% $35,839,112
Financial Services 5.8% $16,795,891
Consumer Defensive 3.3% $9,580,570
Consumer Cyclical 3.2% $9,272,780
Industrials 3.0% $8,600,311
Unclassified 2.6% $7,535,933
Communication Services 2.0% $5,739,893
Energy 1.8% $5,196,423
Utilities 0.9% $2,592,512
Real Estate 0.5% $1,347,151
Basic Materials 0.4% $1,249,399

Portfolio Positions

Export CSV View 13F filing
14 positions · $9,580,570 total · Consumer Defensive only · as of Sep 30, 2023
Ticker Company Shares Value (USD) % of Portfolio History